1. Home
  2. ODP vs TSHA Comparison

ODP vs TSHA Comparison

Compare ODP & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODP
  • TSHA
  • Stock Information
  • Founded
  • ODP 1986
  • TSHA 2019
  • Country
  • ODP United States
  • TSHA United States
  • Employees
  • ODP N/A
  • TSHA N/A
  • Industry
  • ODP Other Specialty Stores
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODP Consumer Discretionary
  • TSHA Health Care
  • Exchange
  • ODP Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • ODP 419.0M
  • TSHA 397.8M
  • IPO Year
  • ODP N/A
  • TSHA 2020
  • Fundamental
  • Price
  • ODP $16.45
  • TSHA $2.71
  • Analyst Decision
  • ODP Hold
  • TSHA Strong Buy
  • Analyst Count
  • ODP 1
  • TSHA 7
  • Target Price
  • ODP $28.00
  • TSHA $7.00
  • AVG Volume (30 Days)
  • ODP 547.1K
  • TSHA 5.2M
  • Earning Date
  • ODP 05-07-2025
  • TSHA 05-15-2025
  • Dividend Yield
  • ODP N/A
  • TSHA N/A
  • EPS Growth
  • ODP N/A
  • TSHA N/A
  • EPS
  • ODP N/A
  • TSHA N/A
  • Revenue
  • ODP $6,820,000,000.00
  • TSHA $7,224,000.00
  • Revenue This Year
  • ODP N/A
  • TSHA N/A
  • Revenue Next Year
  • ODP N/A
  • TSHA N/A
  • P/E Ratio
  • ODP $11.53
  • TSHA N/A
  • Revenue Growth
  • ODP N/A
  • TSHA N/A
  • 52 Week Low
  • ODP $11.85
  • TSHA $1.05
  • 52 Week High
  • ODP $43.31
  • TSHA $4.32
  • Technical
  • Relative Strength Index (RSI)
  • ODP 54.53
  • TSHA 60.38
  • Support Level
  • ODP $15.67
  • TSHA $2.44
  • Resistance Level
  • ODP $16.98
  • TSHA $2.95
  • Average True Range (ATR)
  • ODP 0.78
  • TSHA 0.25
  • MACD
  • ODP -0.17
  • TSHA -0.02
  • Stochastic Oscillator
  • ODP 19.60
  • TSHA 51.60

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on global operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue primarily stems from the Veyer division.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: